NCT02358369 - Dose-Ranging Study of the Bimatoprost Ocular Insert | Biotech Hunter

Enrollment

156

Participants

Timeline

Start Date

January 19, 2015

Primary Completion Date

August 31, 2015

Study Completion Date

October 7, 2015

Conditions

Primary Open-Angle GlaucomaOcular Hypertension

Interventions

DRUG

Bimatoprost

Bimatoprost sustained release Ocular Insert

DRUG

Timolol 0.5%

BID drops OU, 0.5% ophthalmic solution

DEVICE

Placebo Ocular Insert

Placebo ocular insert OU.

DRUG

Placebo Eye Drops

Placebo eye drops BID OU.

Trial Locations (10)

27262

Cornerstone Health Care, High Point

28204

Mundorf Eye Center, Charlotte

30260

Clayton Eye Center, Morrow

37803

University of Eye Specialists, Maryville

38119

Total Eye Care, Memphis

45243

Apex Eye, Madeira

72704

Vold Vision, Fayetteville

78229

R&R Eye Research, LLC, San Antonio

90701

Sall Medical Research Center, Artesia

92663

Eye Research Foundation, Newport Beach

All Listed Sponsors

lead

ForSight Vision5, Inc.

INDUSTRY